BioGaia AB (BGLA) Stock Statistics & Valuation Metrics
Total Valuation
BioGaia AB has a market cap or net worth of EUR 1.12B. The enterprise value is EUR 11.38B.
- Market Cap
- EUR 1.12B
- Enterprise Value
- EUR 11.38B
Share Statistics
BioGaia AB has 98,497,170 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 98,497,170
- Owned by Insiders
- ―
- Owned by Institutions
- 6.55%
Financial Efficiency
BioGaia AB’s return on equity (ROE) is 0.25 and return on invested capital (ROIC) is 23.18%.
- Return on Equity (ROE)
- 0.25
- Return on Assets (ROA)
- 0.21
- Return on Invested Capital (ROIC)
- 23.18%
- Return on Capital Employed (ROCE)
- 0.29
- Revenue Per Employee
- 6.13M
- Profits Per Employee
- 1.33M
- Employee Count
- 251
- Asset Turnover
- 0.96
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of BioGaia AB is 31.55. BioGaia AB’s PEG ratio is 1.31.
- PE Ratio
- 31.55
- PS Ratio
- 7.27
- PB Ratio
- 10.10
- Price to FCF
- 46.55
- Price to Operating Cash Flow
- 43.40
- PEG Ratio
- 1.31
Income Statement
In the last 12 months, BioGaia AB had revenue of 1.54B and earned 332.76M in profits. Earnings per share was 3.29.
- Revenue
- 1.54B
- Gross Profit
- 1.13B
- Operating Income
- 412.47M
- Pretax Income
- 421.22M
- Net Income
- 332.76M
- EBITDA
- 454.33M
- Earnings Per Share (EPS)
- 3.29
Cash Flow
In the last 12 months, operating cash flow was 284.45M and capital expenditures -26.07M, giving a free cash flow of 258.38M billion.
- Operating Cash Flow
- 284.45M
- Free Cash Flow
- 258.38M
- Free Cash Flow per Share
- 2.56
Dividends & Yields
BioGaia AB pays an annual dividend of ―, resulting in a dividend yield of 1.38%
- Dividend Per Share
- ―
- Dividend Yield
- 1.38%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 2.15%
- Earnings Yield
- 3.17%
Stock Price Statistics
- Beta
- 0.15
- 52-Week Price Change
- 22.07%
- 50-Day Moving Average
- 10.35
- 200-Day Moving Average
- 10.48
- Relative Strength Index (RSI)
- 52.46
- Average Volume (3m)
- 283
Important Dates
BioGaia AB upcoming earnings date is Feb 12, 2027, Before Open (Not Confirmed).
- Last Earnings Date
- Oct 28, 2026
- Next Earnings Date
- Feb 12, 2027
- Ex-Dividend Date
- ―
Financial Position
BioGaia AB as a current ratio of 6.12, with Debt / Equity ratio of 0.53%
- Current Ratio
- 6.12
- Quick Ratio
- 6.12
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -1.75
- Interest Coverage Ratio
- 48.84
Taxes
In the past 12 months, BioGaia AB has paid 88.45M in taxes.
- Income Tax
- 88.45M
- Effective Tax Rate
- 0.21
Enterprise Valuation
BioGaia AB EV to EBITDA ratio is 23.20, with an EV/FCF ratio of 44.54.
- EV to Sales
- 6.96
- EV to EBITDA
- 23.20
- EV to Free Cash Flow
- 44.54
- EV to Operating Cash Flow
- 40.46
Balance Sheet
BioGaia AB has EUR 518.27M in cash and marketable securities with EUR 0.00 in debt, giving a net cash position of EUR 518.27M billion.
- Cash & Marketable Securities
- EUR 518.27M
- Total Debt
- EUR 0.00
- Net Cash
- EUR 518.27M
- Net Cash Per Share
- EUR 5.26
- Tangible Book Value Per Share
- EUR 10.51
Margins
Gross margin is 72.74%, with operating margin of 29.01%, and net profit margin of 23.67%.
- Gross Margin
- 72.74%
- Operating Margin
- 29.01%
- Pretax Margin
- 29.82%
- Net Profit Margin
- 23.67%
- EBITDA Margin
- 29.99%
- EBIT Margin
- 28.50%
Analyst Forecast
The average price target for BioGaia AB is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 16.07%
- EPS Growth Forecast
- 27.03%
